CVRx Nominates Michael Dale for Board of Directors
CVRx, Inc. has announced the nomination of Michael Dale to its Board of Directors for election at the annual meeting on June 1, 2026. Michael Dale brings extensive experience from the medical device sector, including his current role as CEO of Axogen, Inc. He has held various leadership positions and board roles in several medical companies. CVRx focuses on developing innovative neuromodulation solutions for cardiovascular diseases.
MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the nomination of Michael Dale to serve on its Board of Directors. Mr. Dale will stand for election at the annual meeting of stockholders scheduled for June 1, 2026.